These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4445444)

  • 21. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.
    Prescott WR; Gold LH; Martin BR
    Psychopharmacology (Berl); 1992; 107(1):117-24. PubMed ID: 1317040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalization of the discriminative stimulus properties of phencyclidine to other drugs in the pigeon using color tracking under second order schedules.
    McMillan DE
    Psychopharmacology (Berl); 1982; 78(2):131-4. PubMed ID: 6817368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of drugs on red cell fragility.
    Mikikits W; Mortara A; Spector RG
    Nature; 1970 Mar; 225(5238):1150-1. PubMed ID: 5418247
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chlordiazepoxide on the acquisition of avoidance learning and its transfer to the normal state and other drug conditions.
    Sachs E; Weingarten M; Klein NW
    Psychopharmacologia; 1966; 9(1):17-30. PubMed ID: 5989100
    [No Abstract]   [Full Text] [Related]  

  • 25. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of withdrawal jumping response in predicting physical dependence in mice.
    Kamei C; Shimomura K; Ueki S
    Jpn J Pharmacol; 1973 Jun; 23(3):421-6. PubMed ID: 4541955
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphine and delta 9-tetrahydrocannabinol: tolerance to the stimulus effects.
    Hirschhorn ID; Rosecrans JA
    Psychopharmacologia; 1974 Apr; 36(3):243-53. PubMed ID: 4858714
    [No Abstract]   [Full Text] [Related]  

  • 29. Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.
    Li M; McMillan DE
    Eur J Pharmacol; 2003 Aug; 476(1-2):79-85. PubMed ID: 12969752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A signal detection analysis of centrally active drugs in mice.
    Gebhart GF; Sherman AD; Lewis VA
    Life Sci; 1980 Dec 22-29; 27(25-26):2633-8. PubMed ID: 7219035
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug discrimination in rats: the effects of phencyclidine and ditran.
    Järbe TU; Johansson JO; Henriksson BG
    Psychopharmacologia; 1975 Apr; 42(1):33-9. PubMed ID: 125431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
    McMillan DE; Sun WL; Hardwick WC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):50-61. PubMed ID: 8764335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of some drugs on an evoked response sensitive to tetrahydrocannabinols.
    Boyd ES; Boyd EH; Brown LE
    J Pharmacol Exp Ther; 1974 Jun; 189(3):748-58. PubMed ID: 4210510
    [No Abstract]   [Full Text] [Related]  

  • 34. Discriminative pentobarbital stimulus in rats immediately after intravenous administration.
    Krimmer EC; Barry H
    Eur J Pharmacol; 1976 Aug; 38(2):321-7. PubMed ID: 954844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.
    Järbe TU; Johansson JO; Henriksson BG
    Psychopharmacology (Berl); 1976 Jul; 48(2):181-7. PubMed ID: 137414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic drug influences on brain acetylcholine utilization.
    Domino EF; Wilson AE
    Psychopharmacologia; 1972; 25(4):291-8. PubMed ID: 5051143
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Pertwee RG; Ross TM
    Neuropharmacology; 1991 Jan; 30(1):67-71. PubMed ID: 1646420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG patterns during the behavioural desensitization to scopolamine in rats.
    Florio V; Bignami G; Longo VG
    Int J Neuropharmacol; 1969 Sep; 8(5):405-11. PubMed ID: 5344486
    [No Abstract]   [Full Text] [Related]  

  • 40. Phencyclidine-induced disruption of an aversely motivated two-choice successive discrimination in the rat.
    Ericson E; Ahlenius S
    Psychopharmacology (Berl); 1990; 102(2):171-4. PubMed ID: 1980371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.